Icon sees more growth after 10% revenue rise

Icon, the listed outsourced pharmaceutical development firm, has announced a 10 per cent increase in revenues in the first quarter of this year.

28th April, 2012
Icon sees more growth after 10% revenue rise
Ciaran Murray, chief executive, Icon.

Icon, the listed outsourced pharmaceutical development firm, believes it can increase its profit margins further in key business areas, after announcing a 10 per cent increase in revenues in the first quarter of this year.

Speaking to investors after the presentation of the company's result, chief executive Ciaran Murray said that the company could increase its Ebidta margins over the next year. "I think it's all about growing our top line and getting leverage from the...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The year in review

Newsround: What Thursday’s papers say